Effects of Nordic walking in Alzheimer’s disease: A single-blind randomized controlled clinical trial
5 Apr 2025
This single-blind randomized clinical trial evaluated the effects of a 24-week Nordic Walking (NW) intervention in patients with mild to moderate Alzheimer’s disease (AD). Thirty patients were assigned to either a control group receiving standard cognitive and physical therapies or an experimental group that also engaged in NW training twice a week. After 24 weeks, the NW group showed significant improvements in cognitive functions, including visual-spatial reasoning, verbal episodic memory, selective attention, and processing speed. Although MMSE scores did not significantly differ between groups, the intervention group maintained cognitive function while the control group showed decline. These findings suggest that NW may be an effective and accessible addition to therapeutic strategies for slowing cognitive decline in early-stage AD.
You may be interested in them
6 Jul 2026
What does the path to perfect technique look like? Interview with Champion Katarzyna Majewska
1 Jul 2026
Self-guided brisk walking training with or without poles: A randomized-controlled trial in middle-aged women
1 Jul 2026
Field testing of physiological responses associated with Nordic Walking
World Original Nordic Walking Federation
Administration office:
JĘDRZYCHOWSKA 20D
65-385 ZIELONA GÓRA, POLAND
office@onwf.org
© 2024 onwf.org | Original Nordic Walking from Finland